Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

SYL-1001 confers analgesia in animal model of ocular pain

May 5, 2011

Hutchison MediPharma presents preclinical data on new small-molecule anticancer agents

May 5, 2011

Methamphetamine-targeted dendribodies show no toxicity in vitro

May 4, 2011

Humanized MAb NEO-201 shows preclinical promise for treatment of solid tumors

May 4, 2011

New frizzled SMO receptor antagonist SEN-450 inhibits tumor growth in vivo

May 4, 2011

K-115 is safe and reduces intraocular pressure in clinical settings

May 4, 2011

12D03 targets mutant epidermal growth factor receptor and has antitumor activity

May 4, 2011

Immunocytokine C2-2b-2b targets IFN-alpha-2b to tumor sites with enhanced antiproliferative activity

May 4, 2011

SNP in CDKN2BAS locus correlates with susceptibility to Ph+ acute lymphoblastic leukemia

May 3, 2011

Topical AMA-0076 reduces intraocular pressure with low systemic exposure

May 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.